Membership
Tour
Register
Log in
Medicinal preparations characterised by the non-active ingredients used
Follow
Industry
CPC
A61K47/00
This industry / category may be too specific. Please go to a parent level for more data
Parent Industries
A
HUMAN NECESSITIES
A61
Medical science
A61K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Current Industry
A61K47/00
Medicinal preparations characterised by the non-active ingredients used
Sub Industries
A61K47/02
Inorganic compounds
A61K47/06
Organic compounds
A61K47/08
containing oxygen
A61K47/10
Alcohols Phenols Salts thereof
A61K47/12
Carboxylic acids Salts or anhydrides thereof
A61K47/14
Esters of carboxylic acids
A61K47/16
containing nitrogen
A61K47/18
Amines Quaternary ammonium compounds
A61K47/183
Amino acids or aminosulphonic acids
A61K47/186
Quaternary ammonium compounds
A61K47/20
containing sulfur
A61K47/22
Heterocyclic compounds
A61K47/24
containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur
A61K47/26
Carbohydrates
A61K47/28
Steroids
A61K47/30
Macromolecular compounds
A61K47/32
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
A61K47/34
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
A61K47/36
Polysaccharides Derivatives thereof
A61K47/38
Cellulose Derivatives thereof
A61K47/40
Cyclodextrins Derivatives thereof
A61K47/42
Proteins Polypeptides Degradation products thereof Derivatives thereof
A61K47/44
Oils, fats or waxes according to more than one of groups A61K47/02 - A61K47/42; Natural or modified natural oils, fats or waxes, e.g.(polyethoxylated) castor oil, montan wax, ozokerite, lignite, shellac, rosin, beeswax, lanolin
A61K47/46
Ingredients of undetermined constitution or reaction products thereof
A61K47/48
the non-active ingredient being chemically bound to the active ingredient
A61K47/48007
the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
A61K47/48015
the modifying agent being an inorganic compound
A61K47/48023
the modifying agent being an organic compound
A61K47/4803
the modifying agent being an organic ion that forms an ion pair complex with the pharmacologically or therapeutically active agent
A61K47/48038
the modifying agent being a carboxylic acid
A61K47/48046
the modifying agent being a lipid
A61K47/48053
the modifying agent being a phospholipid
A61K47/48061
the modifying agent being a heterocyclic compound
A61K47/48069
the modifying agent being a heterocyclic compound which being a porphyrine or a porphyrine with an expanded ring system
A61K47/48076
the modifying agent being a chelate, i.e. single central atom/ion sequestered by a polydentate ligand
A61K47/48084
the modifying agent being a phosphate or phosphonate not being a phospholipid
A61K47/48092
the modifying agent linked to the pharmacologically or therapeutically active agent being a sugar, nucleoside, nucleotide, nucleic acid
A61K47/481
the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
A61K47/48107
one of the codrug's components being a vitamin
A61K47/48115
one of the codrug's components being an antibiotic
A61K47/48123
the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone, bile acid
A61K47/4813
pretargeting systems involving an organic compound, not being a peptide, protein or antibody, for targeting specific cells
A61K47/48138
ECTA, enzyme catalyzed therapeutic agent
A61K47/48146
the modifying agent being biotin
A61K47/48153
the modifying agent being a chemiluminescent acceptor
A61K47/48161
Redox delivery systems
A61K47/48169
the modifying agent being an organic macromolecular compound
A61K47/48176
the organic macromolecular compound has been obtained by reactions only involving carbon-to-carbon unsaturated bonds
A61K47/48184
the macromolecular compound obtained by reactions only involving carbon-to-carbon unsaturated bonds being an ion exchange resin
A61K47/48192
the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
A61K47/482
the macromolecule is/contains a polyester
A61K47/48207
the macromolecule is/contains a polyamide
A61K47/48215
the organic macromolecular compound being a polyoxyalkylene oligomer, polymer, dendrimer
A61K47/48223
the macromolecule contains phosphorus in the main chain
A61K47/4823
the organic macromolecular compound being a polysaccharide or a derivative
A61K47/48238
the modifying agent being a protein, peptide, polyamino acid
A61K47/48246
drug-peptide, protein or polyamino acid conjugates
A61K47/48253
the peptide, protein or polyamino acid in the drug conjugate being a branched, dendritic or hypercomb peptide
A61K47/48261
the peptide or protein in the drug conjugate being a toxin or a lectin
A61K47/48269
the peptide or protein in the drug conjugate being a cytokine
A61K47/48276
the peptide or protein in the drug conjugate being a receptor as such, e.g. CD4; a cell surface antigen (therefore not a peptide ligand targeting the antigen); a cell surface determinant
A61K47/48284
the peptide or protein in the drug conjugate being an albumin
A61K47/48292
the peptide or protein in the drug conjugate being a connective tissue peptide
A61K47/483
the peptide or protein in the drug conjugate being a transferrin
A61K47/48307
the peptide or protein in the drug conjugate being a haemoglobin
A61K47/48315
the peptide or protein in the drug conjugate being a polycationic or polyanionic oligopeptide, polypeptide or polyamino acid
A61K47/48323
polyanionic oligopeptide, polypeptide or polyamino acid, used to complex nucleic acids being the therapeutic agent
A61K47/4833
the entire peptide or protein drug conjugate elicits an immune response
A61K47/48338
peptidic linker, binder, spacer
A61K47/48346
pretargeting systems involving a peptide or protein for targeting specific cells
A61K47/48353
pretargeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
A61K47/48361
Enzyme prodrug therapy
A61K47/48369
the modifying part being an antibody, an immunoglobulin, or a fragment thereof
A61K47/48376
drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
A61K47/48384
drug conjugated to an antibody or immunoglobulin
A61K47/48392
the drug being a vinca alkaloid
A61K47/484
the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid
A61K47/48407
the drug being an antibiotic
A61K47/48415
the drug being a protein or peptide
A61K47/48423
the drug being a peptidic cytokine
A61K47/4843
the drug being an enzyme
A61K47/48438
the drug being a toxin
A61K47/48446
the drug being a plant toxin
A61K47/48453
the drug being a plant heterodimeric toxin; chains A or B containing toxins
A61K47/48461
the drug being ricin (double chain)
A61K47/48469
the drug being a ribosomal inhibitory protein,(RIP-i or RIP-II)
A61K47/48476
the drug being ricin A
A61K47/48484
the drug being a bacterial toxin
A61K47/48492
the drug being a fungal toxin
A61K47/485
the drug being a viral toxin
A61K47/48507
the modifying agent being a well defined antibody or immunoglobulin bearing at least one antigen-binding site
A61K47/48515
not used; see subgroups
A61K47/48523
the antibody being against material from viruses
A61K47/4853
the antibody being targeting a RNA virus
A61K47/48538
the antibody being targeting a material from animals or humans
A61K47/48546
the antibody being targeting a cytokine
A61K47/48553
the antibody being targeting an hormone, or an hormone-releasing or -inhibiting factor
A61K47/48561
the antibody being targeting a receptor, a cell surface antigen, a cell surface determinant
A61K47/48569
the antibody being targeting a determinant of a tumour cell
A61K47/48576
the tumour determinant being carcino-embryonic antigen
A61K47/48584
the tumour determinant being from breast cancer cell
A61K47/48592
the tumour determinant being from lung cancer cell
A61K47/486
the tumour determinant being from liver or pancreas cancer cell
A61K47/48607
the tumour determinant being from kidney or bladder cancer cell
A61K47/48615
the tumour determinant being from stomach or intestines cancer cell
A61K47/48623
the tumour determinant being from skin, nerves or brain cancer cell
A61K47/4863
the tumour determinant being from a cell of a blood cancer
A61K47/48638
the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate
A61K47/48646
the antibody being targeting an enzyme
A61K47/48653
the antibody being targeting an immunoglobulin, being an anti-idiotypic antibody
A61K47/48661
the antibody being a hybrid immunoglobulin
A61K47/48669
the antibody being an immunoglobulin containing regions, domains, residues from different species
A61K47/48676
the immunoglobulin has two or more different antigen-binding sites
A61K47/48684
cluster-antibody conjugates
A61K47/48692
polymer-drug antibody conjugates
A61K47/487
the conjugate or the polymer being a starburst, a dendrimer, a cascade
A61K47/48707
antibody-chelate conjugate wherein the chelate being used for therapeutic purposes
A61K47/48715
conjugates wherein the antibody being the modifying agent and wherein the linker, binder, spacer confers particular properties to the conjugate
A61K47/48723
pretargeting systems involving an antibody for targeting specific cells
A61K47/4873
clearing therapy or enhanced clearance
A61K47/48738
rescue therapy; agonist-antagonist; antidote; targeted rescue or protection
A61K47/48746
two or three steps pretargeting systems, wherein an antibody conjugate being used in at least one of the steps; ligand-antiligand therapy
A61K47/48753
avidin-biotin system wherein at least one avidin- or biotin-conjugated antibody being used in a two- or three-steps pretargeting system
A61K47/48761
ADEPT
A61K47/48769
the conjugate being characterized by a special physical or galenical form
A61K47/48776
forms of ingredients not provided for by groups A61K47/48784 - A61K47/48992
A61K47/48784
the form being semi-solid, an ointment, a gel, a hydrogel, a solidifying gel
A61K47/48792
the form being a colloid, emulsion
A61K47/488
the form being a micro-emulsion, nano-emulsion or micelle
A61K47/48807
micelles formed by phospholipids
A61K47/48815
the form being a liposome
A61K47/48823
the form being a liposome which being modified on its surface by an antibody
A61K47/4883
the form being a polymersome
A61K47/48838
the form being a lipoprotein vesicle
A61K47/48846
the form being a ribbon, tubule cochleate
A61K47/48853
the form being a particulate, powder, adsorbate, bead, sphere
A61K47/48861
the form being an inorganic particle
A61K47/48869
the form being a micro- or nano-capsule or a micro/nano-bubble
A61K47/48876
the form being a solid microparticle having no hollow or gas-filled core
A61K47/48884
the form being a nanoparticle
A61K47/48892
the material constituting the nanoparticle being a polymer
A61K47/489
the material constituting the nanoparticle being a polymer obtained by reactions only involving carbon to carbon
A61K47/48907
the material constituting the nanoparticle being a polymer obtained otherwise than by reactions involving carbon to carbon unsaturated bonds
A61K47/48915
the polymer being PLGA, PLA or polyglycolic acid
A61K47/48923
the polymer being a polysaccharide
A61K47/4893
the form being a granulate or an agglomerate
A61K47/48938
the form being a pill, tablet, lozenge, capsule
A61K47/48946
Microcapsules
A61K47/48953
Nanocapsules; Nanoparticles
A61K47/48961
the conjugate being in the form of a host-guest, i.e. being an inclusion complex
A61K47/48969
inclusion being performed with a cyclodextrin
A61K47/48976
the form being a fibre, textile, slabb, sheet
A61K47/48984
the form being a plaster, bandage, dressing, patch
A61K47/48992
the form being a device, kit .
Industries
Overview
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Therapeutic nanomaterials
Patent number
12,214,043
Issue date
Feb 4, 2025
Yupeng Chen
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Nutritional compositions for the management of hyponatremia
Patent number
12,214,073
Issue date
Feb 4, 2025
NEPHCENTRIC, LLC
Lee Souders
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Micronized lipids
Patent number
12,214,080
Issue date
Feb 4, 2025
MCAL Therapeutics Inc.
Thomas Gadek
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Traditional chinese medicine ointment for preventing and treating m...
Patent number
12,214,006
Issue date
Feb 4, 2025
Hunan University of Science and Engineering
Zongcheng Wang
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Desmopressin oral compositions
Patent number
12,214,010
Issue date
Feb 4, 2025
Tulex Pharmaceuticals Inc.
Yu-Hsing Tu
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Adapter for use in a planetary mixer
Patent number
12,213,941
Issue date
Feb 4, 2025
Medisca Pharmaceutique Inc.
Panagiota Danopoulos
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Colchicine solution
Patent number
12,213,954
Issue date
Feb 4, 2025
PHARMA-DATA RESEARCH AND DEVELOPMENT SINGLE MEMBER S.A.
Ioannis Psarrakis
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Treatment of headache using anti-CGRP antibodies
Patent number
12,215,145
Issue date
Feb 4, 2025
H. Lundbeck A/S
Roger K. Cady
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dih...
Patent number
12,213,967
Issue date
Feb 4, 2025
Deciphera Pharmaceuticals, LLC
Michael D. Kaufman
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Alpha polyglutamated pralatrexate and uses thereof
Patent number
12,213,981
Issue date
Feb 4, 2025
L.E.A.F. Holdings Group LLC
Clet Niyikiza
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Oral cannabinoid formulations
Patent number
12,213,985
Issue date
Feb 4, 2025
Jazz Pharmaceuticals Research UK Limited
Harshit Shah
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Prodrug salts
Patent number
12,213,987
Issue date
Feb 4, 2025
AEROMICS, INC.
Marc F. Pelletier
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
IgG Fc-IL2-Rα-IL2 fusions and methods of use thereof
Patent number
12,215,131
Issue date
Feb 4, 2025
REGENERON PHARMACEUTICALS, INC.
Jiaxi Wu
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Preparation method and application of high-purity plant-derived rec...
Patent number
12,215,139
Issue date
Feb 4, 2025
WUHAN HEALTHGEN BIOTECHNOLOGY CORP.
Daichang Yang
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Antigen binding molecule formats
Patent number
12,215,148
Issue date
Feb 4, 2025
REGENERON PHARMACEUTICALS, INC.
Tong Zhang
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Probiotic composition for prevention of bacterial vaginosis
Patent number
12,214,005
Issue date
Feb 4, 2025
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO
Remco Kort
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Methods of treatment of arthritis and/or psoriasis with pharmaceuti...
Patent number
12,214,013
Issue date
Feb 4, 2025
Amgen Inc.
Monica Goss
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Glucose responsive insulins
Patent number
12,214,018
Issue date
Feb 4, 2025
PROTOMER TECHNOLOGIES, INC.
Alborz Mahdavi
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
PTH prodrugs
Patent number
12,214,020
Issue date
Feb 4, 2025
ASCENDIS PHARMA BONE DISEASES A/S
Kennett Sprogøe
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Polysaccharide and uses thereof
Patent number
12,214,029
Issue date
Feb 4, 2025
GlaxoSmithKline Biologicals SA
Michael T. Kowarik
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Method for stabilization and delivery of therapeutic molecules
Patent number
12,214,042
Issue date
Feb 4, 2025
Nayan Patel
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Factor VIII zwitterionic polymer conjugates
Patent number
12,214,044
Issue date
Feb 4, 2025
KODIAK SCIENCES INC.
Stephen A. Charles
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
FAP-activated proteasome inhibitors for treating solid tumors
Patent number
12,214,047
Issue date
Feb 4, 2025
Trustees of Tufts College
William W. Bachovchin
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Combination of an immune checkpoint modulator and a complex compris...
Patent number
12,214,048
Issue date
Feb 4, 2025
AMAL THERAPEUTICS SA
Madiha Derouazi
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Nanoparticle platform for antibody and vaccine delivery
Patent number
12,214,052
Issue date
Feb 4, 2025
The Hospital for sick Children
Jean-Philippe Julien
B82 - NANO-TECHNOLOGY
Information
Patent Grant
Compositions and methods for treating pain with extracellular vesicles
Patent number
12,213,994
Issue date
Feb 4, 2025
Zeo ScientifiX, Inc.
Maria Ines Mitrani
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
GLP-1 compositions and uses thereof
Patent number
12,214,017
Issue date
Feb 4, 2025
Novo Nordisk A/S
Eva Horn Moeller
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Polyurethane excipient
Patent number
12,214,041
Issue date
Feb 4, 2025
DSM IP Assets B.V.
Jennifer Al-Rashid
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Therapeutic targets for the correction of the human dystrophin gene...
Patent number
12,214,054
Issue date
Feb 4, 2025
Duke University
Charles A. Gersbach
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Drug delivery vehicles for atherosclerosis nanomedicine
Patent number
12,214,076
Issue date
Feb 4, 2025
Northwestern University
Samuel I. Stupp
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Patents Applications
last 30 patents
Information
Patent Application
PROTEIN FORMULATIONS AND USES THEREOF
Publication number
20250042984
Publication date
Feb 6, 2025
CSL INNOVATION PTY LTD
Mouhamad RESLAN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
TARGETING MOIETY-DRUG GRAFTED IMMUNE CELL COMPOSITIONS AND METHODS...
Publication number
20250043023
Publication date
Feb 6, 2025
Arizona Board of Regents on behalf of The University of Arizona
Youngwook WON
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
SMALL MOLECULE IMMUNOPOTENTIATOR CONJUGATES OF NFKB ACTIVATORS AS A...
Publication number
20250041408
Publication date
Feb 6, 2025
The University of Chicago
Aaron ESSER-KAHN
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Stabilized Formulations Containing Anti-BCMA x Anti-CD3 Bispecific...
Publication number
20250041411
Publication date
Feb 6, 2025
Regeneron Pharmaceuticals, Inc.
Kenneth S. Graham
C07 - ORGANIC CHEMISTRY
Information
Patent Application
CONTROLLED-RELEASE CNP AGONISTS WITH INCREASED NEP STABILITY
Publication number
20250041431
Publication date
Feb 6, 2025
ASCENDIS PHARMA GROWTH DISORDERS A/S
Kennett SPROGØE
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
HUMANIZED MUC1 ANTIBODY AND ANTIBODY DRUG CONJUGATE
Publication number
20250041437
Publication date
Feb 6, 2025
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
Nitin Krishnaji DAMLE
C07 - ORGANIC CHEMISTRY
Information
Patent Application
ANTIBODY-DRUG CONJUGATE
Publication number
20250041438
Publication date
Feb 6, 2025
NOVELTY NOBILITY INC.
Sang Gyu PARK
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
NANOMATERIALS
Publication number
20250041441
Publication date
Feb 6, 2025
Beam Therapeutics Inc.
Cory Dane Sago
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Injectable Suspensions
Publication number
20250041206
Publication date
Feb 6, 2025
ASARINA PHARMA AB
Magnus Brisander
C07 - ORGANIC CHEMISTRY
Information
Patent Application
METHOD OF TREATING LIVER STEATOSIS WITH BIOAVAILABLE FORMULATION OF...
Publication number
20250041249
Publication date
Feb 6, 2025
The Regents of the University of California
Daniele Piomelli
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS
Publication number
20250041268
Publication date
Feb 6, 2025
BODOR LABORATORIES, INC.
Nicholas S. BODOR
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITION FOR USE IN THE TREATMENT OF A DISEASE
Publication number
20250041275
Publication date
Feb 6, 2025
Rambam Med-Tech Ltd.
Iyad KHAMAYSI
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
THERAPEUTIC AGENT FOR REFRACTORY VIRAL INFECTIONS
Publication number
20250041326
Publication date
Feb 6, 2025
TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE
Michinori KOHARA
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
GAMMA-POLYGLUTAMIC ACID AND ZINC COMPOSITIONS
Publication number
20250041333
Publication date
Feb 6, 2025
XYLONIX PTE. LTD
Jinhyuk Fred Chung
A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information
Patent Application
VARICELLA ZOSTER VIRUS (VZV) VACCINE
Publication number
20250041407
Publication date
Feb 6, 2025
ModernaTX, Inc.
Giuseppe Ciaramella
B82 - NANO-TECHNOLOGY
Information
Patent Application
ORAL SUSPENSION OF APREMILAST
Publication number
20250041271
Publication date
Feb 6, 2025
Amgen Inc.
Yuchuan Gong
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
FORMULATION FOR THE USE IN THE SIMULTANEOUS TREATMENT OF COCCIDIAL...
Publication number
20250041328
Publication date
Feb 6, 2025
Elanco Animal Health GmbH
Stefan HOFMANN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ACIDIC POLYMER COMPOSITIONS AND METHODS OF USE THEREOF
Publication number
20250041329
Publication date
Feb 6, 2025
NexEos Diagnostics, Inc.
Gerald J. GLEICH
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
TREATMENTS FOR UTERINE FIBROIDS
Publication number
20250041207
Publication date
Feb 6, 2025
RESURGE THERAPEUTICS, INC.
Olof Mikael TROLLSAS
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANTERIOR BLEPHARITIS...
Publication number
20250041212
Publication date
Feb 6, 2025
VISHWANATH PADMANABHAN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
METHOD FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES
Publication number
20250041218
Publication date
Feb 6, 2025
Suntec Medical, Inc.
Chun-Ting Cheng
C07 - ORGANIC CHEMISTRY
Information
Patent Application
METHODS FOR TREATING VISION IMPAIRMENT
Publication number
20250041241
Publication date
Feb 6, 2025
Script Essentials, LLC
Suzy Cohen
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
NICLOSAMIDE FORMULATIONS AND METHODS OF USE
Publication number
20250041253
Publication date
Feb 6, 2025
Florida State University Research Foundation, Inc.
ERIC HOLMES
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Compositions And Methods For Fat Reduction
Publication number
20250041371
Publication date
Feb 6, 2025
Bellasyn, LLC
Diane I. Duncan
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Pharmaceutical composition for antibacterial wound healing comprisi...
Publication number
20250041372
Publication date
Feb 6, 2025
UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY
Yong SHIN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE
Publication number
20250041390
Publication date
Feb 6, 2025
Case Western Reserve University
Anirban Sen Gupta
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY
Publication number
20250041424
Publication date
Feb 6, 2025
Takeda Pharmaceutical Company Limited
Willow Diluzio
C07 - ORGANIC CHEMISTRY
Information
Patent Application
DINUCLEAR PHOSPHANE GOLD(I) COMPLEXES FOR TREATING CANCER
Publication number
20250041427
Publication date
Feb 6, 2025
KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS
Adam Ahmed Abdallah SULAIMAN
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
PROCESSES FOR THE FORMULATION OF PNEUMOCOCCAL POLYSACCHARIDES FOR C...
Publication number
20250041428
Publication date
Feb 6, 2025
Merck Sharp & Dohme LLC
Patrick McHugh
C07 - ORGANIC CHEMISTRY
Information
Patent Application
CEA ASSAY FOR PATIENT SELECTION IN CANCER THERAPY
Publication number
20250041434
Publication date
Feb 6, 2025
SANOFI
Mustapha CHADJAA
G01 - MEASURING TESTING